44(8): 15259 Longo A, Bruno G, Curti S, et al
"[December 2025] was one of the darkest times of my life, and it was scary," Bunnie, a podcast host and author, said
Broccoli sprouts The amount of glucoraphanin, the precursor of sulforaphane, in broccoli seeds remains more or less constant as those seeds germinate and grow into mature plants
Potassium: Key for a steady heart rhythm
The lawsuits name pharmaceutical companies responsible for manufacturing and marketing GLP-1 medications without adequate warnings: Novo Nordisk, the maker of Ozempic (for type 2 diabetes), Wegovy (for weight loss), and Rybelsus (oral semaglutide for diabetes) Eli Lilly, the maker of Trulicity (dulaglutide) and Mounjaro (tirzepatide), which are also GLP-1 receptor agonists associated with similar gastrointestinal risks These companies marketed their products heavily, particularly for weight loss, without fully disclosing the potential for severe and potentially permanent digestive complications